A single dose of MM120, a pharmaceutical-grade LSD compound, could mark a breakthrough in treating generalized anxiety disorder (GAD), according to a new phase 2b clinical trial published in JAMA.

#LSDTherapy #AnxietyTreatment #MentalHealth #Neuroplasticity #MM120 #Psychiatry